GEO Accession viewer

NCBI > GEO > Accession Display

Not logged in | Login

GEO help: Mouse over screen elements for information.

Series GSE2149

Query DataSets for GSE2149

Status

Public on Jan 16, 2005

Title

Gene Expression Profile of Primary Effusion Lymphoma

Organism

Homo sapiens

Experiment type

Expression profiling by array

Summary

Primary effusion lymphomas (PELs) are specifically associated with KSHV/HHV-8 infection, and most frequently occur in HIV-positive individuals as lymphomatous effusions in the serous cavities without a detectable solid tumor mass. Most PELs have concomitant EBV infection, suggesting that EBV is an important pathogenetic co-factor, although other as yet unidentified cofactors, such as cellular genetic alterations, are also likely to play a role. Lymphomatous effusions that lack KSHV also occur; these are frequently EBV-associated in the setting of HIV infection. Here we used gene expression profile analysis to determine the viral impact on cellular gene expression and the pathogenesis of these lymphomatous effusions.
We used the Affymetrix HG-U133A microarray to analyze the gene expression profile of these effusion lymphomas (three virologic groups: KSHV-positive EBV-positive PELs, KSHV-positive EBV-negative PELs and KSHV-negative EBV-positive lymphomatous effusions). Nine cell lines derived from patients with lymphomatous effusions (three from each virologic group and each cell line was done in duplicates.) and three PEL patient samples were used in the study. Our results suggest that KSHV-positive PELs are very different from KSHV-negative lymphomatous effusions, and the genes that are differentially expressed include apoptosis regulators, cell cycle regulators, transcriptional factors and signal transduction regulators. KSHV clearly plays a dominant role in the phenotype of PEL. Within the KSHV-positive PELs, two subgroups can be identified, which were correlated with their EBV viral status. Among these genes (45 gene probes), four were regulators of the MAP kinase pathway that were up-regulated in the KSHV-positive, EBV-negative PELs, suggesting that in the absence of EBV, events that lead to the activation of the MAP kinase pathway may act as a cofactor for the development of PEL. Next we determined whether we could predict the viral status of the three primary patient cases of PEL based on the 45 gene probes that were differentially expressed in KSHV-positive cell lines according to EBV status (pt. 1: KSHV-positive, EBV-positive; Pt. 2: KSHV-positive, low proportion of EBV-positive; pt. 3: KSHV-positive EBV-negative), and we could.
Samples:
KSHV-positive EBV-positive cell lines: BC-1, BC-2, BC-5
KSHV-positive EBV-negative cell lines: BC-3, BCBL-1, PEL-5
KSHV-negative EBV-positive cell lines: IBL4, SM1, BCKN-1
pt. 1: KSHV-positive, EBV-positive
pt. 2: KSHV-positive, EBV-positive (low number of positive cells)
pt. 3: KSHV-positive, EBV-negative

Keywords: other

Contributor(s)

Fan W, Bubman D, Chadburn A, Harrington WJ Jr, Cesarman E, Knowles DM

Citation missing

Has this study been published? Please login to update or notify GEO.

Submission date

Jan 12, 2005

Last update date

Aug 10, 2018

Contact name

wen fan

E-mail(s)

[email protected]